Atlas Trials

Study of Post-Exposure Ingavirin® Prophylaxis of Influenza and Acute Respiratory Viral Infections

Clinical trial NCT03189537 · COMPLETED

Trial details

NCT number
NCT03189537
Sponsor
Valenta Pharm JSC
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Influenza, HumanAcute Respiratory InfectionCommon ColdFluViral Infection
Start date
2010-10-03
Primary completion
2011-04-19
Enrollment
400

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.